TrialJournal of translational medicine2023

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial.

Guozhen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.